768 related articles for article (PubMed ID: 10649257)
1. Flat intraepithelial lesions of the urinary bladder.
Cheng L; Cheville JC; Neumann RM; Bostwick DG
Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
[TBL] [Abstract][Full Text] [Related]
2. Intraepithelial lesions of urinary bladder: morphologic considerations.
Murphy WM; Busch C; Algaba F
Scand J Urol Nephrol Suppl; 2000; (205):67-81. PubMed ID: 11144906
[TBL] [Abstract][Full Text] [Related]
3. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with carcinoma in situ of the urinary bladder.
Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG
Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420
[TBL] [Abstract][Full Text] [Related]
5. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
Sibony M; Billerey C
Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
[TBL] [Abstract][Full Text] [Related]
6. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
7. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
[TBL] [Abstract][Full Text] [Related]
8. Urothelial papilloma of the bladder. Clinical and biologic implications.
Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG
Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437
[TBL] [Abstract][Full Text] [Related]
9. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications.
Cheng L; Neumann RM; Bostwick DG
Cancer; 1999 Nov; 86(10):2102-8. PubMed ID: 10570438
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
12. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of denuded urothelium in bladder biopsy.
Levi AW; Potter SR; Schoenberg MP; Epstein JI
J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
15. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
[TBL] [Abstract][Full Text] [Related]
16. Significance of denuded urothelium in papillary urothelial lesions.
Owens CL; Epstein JI
Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
[TBL] [Abstract][Full Text] [Related]
17. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
Kryvenko ON; Epstein JI
J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
[TBL] [Abstract][Full Text] [Related]
18. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
19. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.
Gunia S; Kakies C; May M; Koch S; Erbersdobler A
J Clin Pathol; 2011 Aug; 64(8):672-6. PubMed ID: 21512109
[TBL] [Abstract][Full Text] [Related]
20. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.
Kapur U; Antic T; Venkataraman G; Durazo-Arvizu R; Quek MM; Flanigan RC; Wojcik EM
Urology; 2007 Nov; 70(5):1028-33. PubMed ID: 18068480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]